The purpose is to evaluate implementation of a community-based prevention project aimed at increasing early detection and prevention of breast and cervical cancer through education and navigation and to increase breast and cervical cancer screening and Human Papillomavirus (HPV) vaccination in underserved Latinas.
This is an evaluation of the Salud en Mis Manos community health worker-delivered breast and cervical cancer screening promotion program. The investigators evaluate the effect of the program on increasing participant breast and cervical cancer screening and HPV vaccination, using a one-group pre-post study design (March 2017 - May 2019). The investigators also describe the implementation of the program during a longer time period (November 2016 - May 2019).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
8,262
Education will be delivered in person in a group education setting or individually by phone. Group education will include 1 hour breast and cervical cancer prevention education session delivered with support of electronic presentations. For phone education, trained project staff or Community Health Workers (CHWs) will deliver telephone-based education as an alternative to group education session for women who missed scheduled session twice (education materials would be printed and mailed).
Continue telephone based navigation tailored to participants' barriers using the Cancer Prevention Plan of Action to support, problem solve, assist, and provide reminders to increase utilization of clinic services.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Number of women 40 years and older who complete mammogram screening
Among women 40 years and older that have not had a mammogram in the past two years, enrolled in the program and completed baseline and follow-up surveys.
Time frame: Between baseline and end of study (about 9 months)
Number of women 21-65 years old who complete Pap test screening
Among women 21 - 65 years old that have not had a Pap test in the past three years, enrolled in the program and completed baseline and follow-up surveys.
Time frame: Between baseline and end of study (about 9 months)
Number of women 21-26 years old who initiate their HPV vaccination series.
Among women 21-26 years old that have not yet initiated their HPV vaccination series, enrolled in the program and completed baseline and follow-up surveys.
Time frame: between baseline and end of study (about 9 months)
Number of participants who received the second dose of HPV vaccine
Among women that have not had their second HPV vaccination dose, enrolled in the program and completed baseline and follow-up surveys.
Time frame: between baseline and end of study (about 9 months)
Number of participants who received the third dose of HPV vaccine
Among women that have not had their third HPV vaccination dose, enrolled in the program and completed baseline and follow-up surveys.
Time frame: between baseline and end of study (about 9 months)
Number of participants who received a clinical breast exam
Among women that have not had a mammogram in the past two years, enrolled in the program and completed baseline and follow-up surveys.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: between baseline and end of study (about 9 months)